Previous 10 | Next 10 |
China Biologic Products (NASDAQ: CBPO ): Q1 Non-GAAP EPS of $1.11 beats by $0.13 ; GAAP EPS of $0.94 beats by $0.26 . Revenue of $129.8M (+15.4% Y/Y) beats by $10.3M . Press Release More news on: China Biologic Products Holdings, Inc., Earnings news and commentary, Healthcare stoc...
--1Q19 Total Sales Up 15.4% YoY in USD terms, or 22.3% YoY in RMB terms; Net Income Up 19.3% YoY to $37.7 Million ; Non-GAAP Adjusted Net Income Up 14.3% YoY in RMB terms -- BEIJING , May 10, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biolog...
CBPO For Seeking Alpha's full earnings season calendar, click here . More news on: China Biologic Products Holdings, Inc., Earnings news and commentary, ,
BEIJING , April 30, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China , today announced that the Company plans to release its first quarter 2019 f...
Source: Shutterstock The stock market has continued to edge higher and the two major indexes, the Nasdaq ( QQQ ) and S&P 500 ( SPY ), touched the all-time high milestone last week. The steady gain reflects a diminishing concern relating to the pace of a global economic slowdown, as m...
China Biologic Products, Inc. (CBPO) Q4 2018 Earnings Conference Call March 07, 2019 07:30 AM ET Company Participants Sam Martin - IR Bing Li - CEO Ming Yin - SVP Ming Yang - CFO Conference Call Participants Yolanda Hu - Morgan Stanley Serena Shao - Credit Suisse Pre...
China Biologic Products (NASDAQ: CBPO ): Q4 Non-GAAP EPS of $0.76 misses by $0.07 ; GAAP EPS of $0.86 beats by $1.71 . More news on: China Biologic Products, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
-- 4Q18 Total Sales Up 27.5% YoY in USD terms, or 33.5% YoY in RMB terms; Net Income Up $59.4 Million YoY to $34.8 Million ; Non-GAAP Adjusted Net Income Up 23.9% YoY in RMB terms -- -- FY18 Total Sales Up 26.1% YoY in USD terms, or 23.5% YoY in RMB terms; Net Income Up 88.7% Y...
ABM , ASRT , BLDP , BREW , CBPO , DSGX , FTK , GWRE , HIIQ , WHD , YEXT For Seeking Alpha's full earnings season calendar, click here . More news on: ABM Industries Incorporated, Assertio Therapeutics Inc, Ballard Power Systems, Inc., Earnings news and commentary,
BEIJING , Feb. 25, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China , today announced that the Company plans to release its fourth quarter and fi...
News, Short Squeeze, Breakout and More Instantly...
China Biologic Products Holdings Inc. Company Name:
CBPO Stock Symbol:
NASDAQ Market:
China Biologic Products Holdings Inc. Website:
Leading English language training provider Meten Holding Group’s (METX) stock has soared 54.5% in price over the past month thanks to the company’s strategic collaboration with AGM Group Holdings. However, given the company’s negative profit margins and mixed financials, ...
Currently trading at less than $1, the shares of China-based BIMI International Medical’s (BIMI) have dipped 72.2% in price over the past year. So, given the company’s weak financials and poor profitability, will its stock be able to regain its momentum? Read more to find out. ...
China Biologic Announces Completion of Going Private Transaction PR Newswire BEIJING , April 20, 2021 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmac...